Navigation Links
Cogentus Pharmaceuticals Begins Clinical Study to Confirm the Full Antiplatelet Benefit of New Combination Medicine CGT-2168
Date:1/16/2008

MENLO PARK, Calif., Jan. 16 /PRNewswire/ -- Cogentus Pharmaceuticals, Inc. today announced that dosing has begun in a clinical study to confirm the full antiplatelet activity of its novel combination medicine CGT-2168. CGT-2168 is a once-daily capsule that combines clopidogrel (currently marketed by Bristol-Myers Squibb Co. and Sanofi-Aventis as Plavix(R)) with a gastroprotectant (omeprazole) to improve the gastrointestinal safety of antiplatelet therapy.

(Logo: http://www.newscom.com/cgi-bin/prnh/20071112/COGENTUSLOGO)

The crossover study (CG106) will characterize the pharmacodynamic effects of CGT-2168 compared with Plavix and will expand earlier findings of comparability. "In a previous clinical trial we demonstrated that the absorption of CGT-2168 is equivalent to that of Plavix, and that the omeprazole component within CGT-2168 does not interfere with the metabolism of the clopidogrel component," said Cogentus Chairman and Chief Executive Officer Mark A. Goldsmith, M.D., Ph.D.

An independent study published this week in the Journal of the American College of Cardiology showed that commercially available omeprazole significantly decreases the antiplatelet activity of Plavix when the two medicines are co-administered. "This finding is consistent with our own earlier clinical data that revealed an adverse drug interaction between Plavix and Prilosec(R) (marketed omeprazole), and may raise serious concerns for patients and practitioners," Dr. Goldsmith said. "However, these findings contrast with the properties we have observed with our unique formulation, CGT-2168. We expect the CG106 trial to confirm that CGT-2168 exhibits full antiplatelet activity and avoids the drug-drug interaction reported with the individual drugs on the market today."

Separately, Cogentus has begun COGENT-1, a global Phase 3 trial that will evaluate the clinical benefits
'/>"/>

SOURCE Cogentus Pharmaceuticals, Inc.
Copyright©2008 PR Newswire.
All rights reserved

Page: 1 2

Related medicine technology :

1. Cogentus to Launch Phase III Program of Novel Combination Product Designed to Reduce Bleeding Side Effect of Antiplatelet Therapy
2. First Patient Enrolled in Cogentus Pharmaceuticals Pivotal Phase 3 Trial of Novel Combination Medicine
3. Auxilium Pharmaceuticals, Inc. Receives Clearance to Resume Clinical Trials for XIAFLEX(TM)
4. Vion Pharmaceuticals Completes Accrual of 85 Patients to its Pivotal Phase II Trial of Cloretazine(R) (VNP40101M) in Elderly AML
5. Solvay Pharmaceuticals, Inc. and Wyeth Pharmaceuticals Announce Receipt of an FDA Action Letter for Bifeprunox, an Investigational Treatment for Schizophrenia
6. Callisto Pharmaceuticals Opens Additional Sites for Phase II Clinical Trial of Atiprimod in Advanced Carcinoid Cancer Patients
7. WallSt.net (www.wallst.net) Updates the Investment Community Through an All-New Interview With RegeneRx Biopharmaceuticals CEO
8. Quark Pharmaceuticals, Inc. Presented Positive Preclinical Results of Systemic RNAi Compound for Acute Renal Failure (ARF)
9. Peregrine Pharmaceuticals Doses First Patient in Cotara(R) Phase II Brain Cancer Trial In India
10. Nabi Biopharmaceuticals Announces Second Quarter 2007 Financial Results
11. Access Pharmaceuticals Provides Update on Clinical Development Plan of ProLindac
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:9/22/2014)... Avanir Pharmaceuticals, Inc. (NASDAQ: AVNR ... $200 million of its common stock in an underwritten ... Merrill Lynch are acting as joint book-running managers for ... option to purchase additional shares of its common stock. ... offering are being sold by Avanir.  The offering is ...
(Date:9/22/2014)... Sept. 22, 2014 Research and Markets ... for Neurotechnology: 2014-2018" report to their offering. ... the most comprehensive and up-to-date publication available covering the ... the technology, markets, competitors, and growth rates in four ... 2014 through 2018. It forecasts the number of systems ...
(Date:9/22/2014)... , Sept. 22, 2014 Research ... "PCSK9 and Other Novel Hypercholesterolemia Drugs" report ... that there is a high cholesterol burden despite the ... of all the available options, statins have been ubiquitously ... that reduction of plasma LDL cholesterol (LDLC) is the ...
Breaking Medicine Technology:Avanir Pharmaceuticals Announces Proposed Public Offering of Common Stock 2Avanir Pharmaceuticals Announces Proposed Public Offering of Common Stock 3The Market for Neurotechnology: 2014-2018 2PCSK9 and Other Novel Hypercholesterolemia Drugs 2PCSK9 and Other Novel Hypercholesterolemia Drugs 3
(Date:9/22/2014)... PA (PRWEB) September 22, 2014 The ... in the Greater Philadelphia region each year, is considered ... year, CNC manufacturer MK Precision is proud to announce ... accomplished group. MK Precision will attend the Philadelphia ... one of the premiere business events of the year, ...
(Date:9/22/2014)... study pulls back the curtain on one of the ... and income between physicians who perform operations, procedures or ... perception, the research indicates, the physician payment system is ... doctors. , The new findings counter the widely held ... explains why doctors who perform procedures often earn nearly ...
(Date:9/22/2014)... HealthDay Reporter MONDAY, Sept. 22, 2014 ... aware of online physician-rating sites, and more than one-quarter have ... to a new national study. The findings -- based ... that negative online ratings may dissuade parents from choosing a ... neighbor. Conversely, a positive online rating may sway parents ...
(Date:9/22/2014)... Asians living in Canada have a higher rate of ... with while people, McMaster researchers have found. , ... Medical Association Journal (CMAJ Open) and may be ... fastest-growing ethnic groups in the country is the more ... comprising about three percent of the population. They include ...
(Date:9/22/2014)... 2014. Kessler researchers have published a pilot study ... program in people with multiple sclerosis (MS). ... perceived stress, and pain. "Development and effectiveness ... with MS: Description and outcomes" was epublished ahead ... International Journal of MS Care (doi: 10.7224/1537-2073.2013-045). ...
Breaking Medicine News(10 mins):Health News:MK Precision Announces Spot on Philadelphia 100 Fastest Growing Companies 2Health News:Think the system for paying US doctors is rigged to favor surgeons? Study may surprise you 2Health News:Think the system for paying US doctors is rigged to favor surgeons? Study may surprise you 3Health News:Think the system for paying US doctors is rigged to favor surgeons? Study may surprise you 4Health News:Many Parents Use Online Ratings to Pick a Pediatrician, Study Finds 2Health News:Many Parents Use Online Ratings to Pick a Pediatrician, Study Finds 3Health News:Higher risk of heart disease for South Asians in Canada 2
... Oct. 21 Today more than ever, employers,are looking ... call for stabilizing influences, and wellness is such an,influence," ... time to put workplace wellness and employee health on ... to begin to realize the financial and,other benefits of ...
... celebrates the contributions that pharmacy technicians make on the 18th ... ... Washington, D.C. (PRWEB) October 21, 2008 -- Today marks ... Pharmacy Technician Certification Board (PTCB) applauds the valuable contributions ...
... While a poverty-alleviation program launched by the Mexican government ... around the world has led to improved health and ... of California, Berkeley, researchers says that the cash component ... The program, called Oportunidades, provides money to impoverished families ...
... Announces It Reduced Debt by $6.1 Million in ... 21 LodgeNet,Interactive Corporation (Nasdaq: LNET ), ... hospitality and healthcare businesses, today,announced that it will ... Tuesday, October 28, 2008., (Logo: http://www.newscom.com/cgi-bin/prnh/20080115/AQTU120LOGO ...
... Inc. (OTC,Bulletin Board: VSPC) subsidiary Ionfinity has ... its proposal entitled "Miniature Electronic Sniffer,for Navy ... by the Navy,s,Small Business Technology Transfer (STTR) ... result in a field demonstration of high,sensitivity ...
... ProLindac Is Safe And Active in Recurrent Ovarian ... DALLAS, Oct. 21 ACCESS PHARMACEUTICALS, INC.,(OTC Bulletin ... recent results of the company,s proprietary polymer DACH,platinum ... being,presented this week at a major international oncology ...
Cached Medicine News:Health News:Even During Financial Crisis Investing in Wellness is Good Business 2Health News:National Pharmacy Technician Day Celebrated with Focus on Quality -- Pharmacy Technician Certification Board (PTCB) Touts Importance of Certified Technicians 2Health News:National Pharmacy Technician Day Celebrated with Focus on Quality -- Pharmacy Technician Certification Board (PTCB) Touts Importance of Certified Technicians 3Health News:Extra cash from government program linked to higher risk of adult obesity 2Health News:Extra cash from government program linked to higher risk of adult obesity 3Health News:LodgeNet Interactive to Report Third Quarter Results on October 28th 2Health News:VIASPACE Subsidiary Wins $786,000 U.S. Navy Contract 2Health News:Access Pharmaceuticals Presents ProLindac(TM) Data at the AACR-NCI-EORTC Symposium 2008 2Health News:Access Pharmaceuticals Presents ProLindac(TM) Data at the AACR-NCI-EORTC Symposium 2008 3
... national reference laboratory and a worldwide leader ... offers an extensive test menu of highly ... and anatomic pathology. Owned by the University ... than half of the nation's university teaching ...
... a national reference laboratory and a worldwide ... ARUP offers an extensive test menu of ... clinical and anatomic pathology. Owned by the ... more than half of the nation's university ...
... Laboratories is a national reference laboratory and ... and development. ARUP offers an extensive test ... tests in clinical and anatomic pathology. Owned ... clients include more than half of the ...
... reference laboratory and a worldwide leader in ... an extensive test menu of highly complex ... anatomic pathology. Owned by the University of ... half of the nation's university teaching hospitals ...
Medicine Products: